Virulence attributes in Brazilian clinical isolates of Pseudomonasaeruginosa

Silva, Lívia V.; Galdino, Anna Clara M.; Nunes, Ana Paula F.; Santos, Kátia R. N. dos; Moreira, Beatriz M.; Cacci, Luciana C.; Sodré, Catia I.; Ziccardi, Mariangela; Branquinha, Marta H.; Santos, André L. S..
Artículo en Inglés | ARCA | ID: arc-11943

Documentos relacionados

  1. Quercetin: a promising virulence inhibitor of Pseudomonas aeruginosa LasB in vitro.
  2. Arginine Gemini-Based Surfactants for Antimicrobial and Antibiofilm Applications: Molecular Interactions, Skin-Related Anti-Enzymatic Activity and Cytotoxicity.
  3. Chemical Optimization of Selective <i>Pseudomonas aeruginosa</i> LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1ß in Cellular and Animal Infection Models.
  4. Inhibition of the Quorum Sensing System, Elastase Production and Biofilm Formation in <i>Pseudomonas aeruginosa</i> by Psammaplin A and Bisaprasin.
  5. [Pseudomonas aeruginosa virulence factors as a therapeutic target in multidrug-resistant strains].
  6. Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients.
  7. The Rhl Quorum-Sensing System Is at the Top of the Regulatory Hierarchy under Phosphate-Limiting Conditions in Pseudomonas aeruginosa PAO1.
  8. Novel quinoline-based derivatives as the PqsR inhibitor against Pseudomonas aeruginosa PAO1.
  9. Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of <i>Escherichia coli, Mycobacterium tuberculosis, Pseudomonas aeruginosa</i>, and <i>Staphylococcus aureus</i>.
  10. Mutational analysis on stable expression and LasB inhibition of LasB propeptide in Pseudomonas aeruginosa.